泛癌蛋白质组和转录组PD-1/PD-L1信号元分析:发现抗PD-1治疗肺癌的预测生物标志物
12种癌症类型的PD-1/PD-L1信号通路蛋白质组和转录组元分析,用于发现抗PD-1治疗肺癌的预测生物标志物。

基本信息
资源简介
泛癌蛋白质组和转录组PD-1/PD-L1信号元分析:发现抗PD-1治疗肺癌的预测生物标志物
【数据集背景】
本数据集源站标题为《Pan-Cancer
Proteomic and Transcriptomic Meta-Analysis
of PD-1/PD-L1 Signaling Reveals Predictive Biomarkers for Anti-PD‑1
Therapy in Lung Cancer》。配套论文《Pan-Cancer Proteomic and Transcriptomic Meta-Analysis of PD-1/PD-L1 Signaling Reveals Predictive Biomarkers for Anti-PD-1 Therapy in Lung Cancer》发表于 Journal of Proteome Research(2026),DOI:10.1021/acs.jproteome.5c01238。源站首次发布:2026-03-30。
【数据内容】
源站原始描述:Programmed death-ligand 1 (PD-L1) is an immune checkpoint molecule that enables tumor cells to escape immune surveillance, and its blockade by immune checkpoint inhibitors has become an effective therapeutic strategy in various cancers. Previous studies have primarily focused on genomic and transcriptomic features within specific cancer types, while proteomic analyses remain relatively limited. Here, we conducted a comprehensive pan-cancer meta-analysis encompassing 12 human cancer types to syst…
【数据结构与技术规格】
文件数 1 个,合计 192.74 KB。pr5c01238_si_005.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,192.74 KB。数据集 DOI:10.1021/acs.jproteome.5c01238.s005。
【主题与分类】
源站学科分类:Space Science、Medicine、Cell Biology、Environmental Sciences not elsewhere classified、Immunology、Biological Sciences not elsewhere classified。主题标签:sup >+</ sup、predicting clinical response、potential predictive biomarkers、interactive web application、identified tap proteins、https :// yuyingsuo、enables tumor cells、effective therapeutic strategy、biomarker signature capable、observed clear cancer。
【适用方向】
组学数据适用于生物标志物发现与分子分型相关建模研究。
【获取与许可】
源站页面:https://acs.figshare.com/articles/dataset/Pan-Cancer_Proteomic_and_Transcriptomic_Meta-Analysis_of_PD-1_PD-L1_Signaling_Reveals_Predictive_Biomarkers_for_Anti-PD_1_Therapy_in_Lung_Cancer/31889092
使用许可:CC BY-NC 4.0(https://creativecommons.org/licenses/by-nc/4.0/)。
规范引用:Suo, Yuying; Song, Yuanli; Zhou, Hu; Liu, Qian (2026). Pan-Cancer Proteomic and Transcriptomic Meta-Analysis of PD-1/PD-L1 Signaling Reveals Predictive Biomarkers for Anti-PD‑1 Therapy in Lung Cancer. ACS Publications. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Pan-Cancer
Proteomic and Transcriptomic Meta-Analysis
of PD-1/PD-L1 Signaling Reveals Predictive Biomarkers for Anti-PD‑1
Therapy in Lung Cancer - DOI:10.1021/acs.jproteome.5c01238.s005
- 发布日期:2026-03-30
- 文件数:1 个
- 文件总体积:192.74 KB
- 源站页面:https://acs.figshare.com/articles/dataset/Pan-Cancer_Proteomic_and_Transcriptomic_Meta-Analysis_of_PD-1_PD-L1_Signaling_Reveals_Predictive_Biomarkers_for_Anti-PD_1_Therapy_in_Lung_Cancer/31889092
命令行下载
curl -L -o "pr5c01238_si_005.xlsx" "https://ndownloader.figshare.com/files/63279361"
文件清单
pr5c01238_si_005.xlsx(192.74 KB)
文件总体积 192.74 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Programmed death-ligand 1 (PD-L1)
is an immune checkpoint
molecule
that enables tumor cells to escape immune surveillance, and its blockade
by immune checkpoint inhibitors has become an effective therapeutic
strategy in various cancers. Previous studies have primarily focused
on genomic and transcriptomic features within specific cancer types,
while proteomic analyses remain relatively limited. Here, we conducted
a comprehensive pan-cancer meta-analysis encompassing 12 human cancer
types to systematically characterize PD-1/PD-L1 signaling pathways
at both the proteomic and transcriptomic levels. We observed clear
cancer-type-specific patterns of PD-1/PD-L1 expression. Pathway-crosstalk
analyses further revealed multiple pathways and phosphorylation events
influencing PD-1/PD-L1 activity. Immune-infiltration profiling identified
MMP9+ neutrophils as key immune subsets associated with
PD-1/PD-L1 pathway activity. Using proteomic data, we constructed
a PD-L1-centered protein–protein interaction network and identified
TAP proteins as potential predictive biomarkers in small-cell lung
cancer. We also established a biomarker signature capable of predicting
clinical response to anti-PD-1 therapy in non-small-cell lung cancer
and validated this gene set in two independent previously published
cohorts. Finally, we developed an interactive web application (https://yuyingsuo-simm.shinyapps.io/PD-L1_Profiling/) to facilitate visualization of PD-L1 features and exploration of
its associations with genes and pathways of interest.
许可
CC BY-NC 4.0
引用
学术使用请引用 DOI 10.1021/acs.jproteome.5c01238.s005(source: https://acs.figshare.com/articles/dataset/Pan-Cancer_Proteomic_and_Transcriptomic_Meta-Analysis_of_PD-1_PD-L1_Signaling_Reveals_Predictive_Biomarkers_for_Anti-PD_1_Therapy_in_Lung_Cancer/31889092)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




